Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.56 |
| ▸ | MMP9 | P14780 | 2/20 | 0.56 |
| ▸ | PLAU | P00749 | 4/20 | 0.47 |
| ▸ | HPN | P05981 | 4/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 2/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1305743 | 1.00 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL200245 | 0.89 | MMP2 (0.57) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL200247 | 0.89 | MMP2 (0.57) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL11406948 | 0.88 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL920895 | 0.88 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL15537019 | 0.87 | MMP2 (0.55) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL28509074 | 0.86 | MMP2 (0.60) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL77677 | 0.86 | MMP9 (0.67) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL2038720 | 0.86 | MMP9 (0.67) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL1499337 | 0.85 | MMP9 (0.65) | MMP2MMP9PLAUHPNITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12203936-B2 | Detection of glutathionylated proteins | UNIVERSITEIT MAASTRICHT (NL) | 2025-01-21 | — | — | US | claimed |
| US-20210311057-A1 | DETECTION OF GLUTATHIONYLATED PROTEINS | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2021-10-07 | — | — | US | claimed |
| US-20180224452-A1 | DETECTION OF GLUTATHIONYLATED PROTEINS | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2018-08-09 | — | — | US | claimed |
| US-20150056633-A1 | DETECTION OF GLUTATHIONYLATED PROTEINS | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2015-02-26 | — | — | US | claimed |
| US-8512679-B2 | Glassy compositions | ELWHA LLC (US) | 2013-08-20 | — | — | US | claimed |
| US-20120225011-A1 | Glassy compositions | Elwha LLC, a limited liability company of the State of Delaware | 2012-09-06 | — | — | US | claimed |
| US-20080014595-A1 | Detection of glutathionylated proteins | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2008-01-17 | — | — | US | claimed |
| WO-2007087365-A2 | DETECTION OF GLUTATHIONYLATED PROTEINS | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2007-08-02 | — | — | WO | claimed |
| WO-2005101019-A2 | DETECTION OF NITROSYLATED PROTEINS | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2005-10-27 | — | — | WO | claimed |
| US-5731198-A | COMPRISING AN ENZYME INHIBITOR SUPPORTED ON A POROUS MEMBER | EMERALD BIOMEDICAL SCIENCES, INC. (US) | 1998-03-24 | — | — | US | claimed |
| US-5385825-A | An enzyme inhibitor consisting of blood, ethylenediamine tetraacetic acid and at least one compound from N-tosyl-lysyl chloromethylketone and N-tosyl-phenylalanyl chloromethylketone ; radioimmunoassay detecting a protein or hormone analyte | EMERALD BIOMEDICAL SCIENCES, INC. (US) | 1995-01-31 | — | — | US | claimed |
| EP-0230670-A2 | Novel host E. coli and use thereof | SUNTORY LIMITED (JP) | 1987-08-05 | — | — | EP | claimed |
| JP-4182423-A | — | — | None | — | — | JP | disclosed |
| US-20260124259-A1 | STAPHYLOCOCCUS PHAGE COMPOSITIONS AND COCKTAILS THEREOF | Locus Biosciences, Inc. (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115275-A1 | RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF | UNIV CALIFORNIA (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4727556-A2 | SEQUESTRANT COMPOUNDS FOR ALPHA 2 ADRENERGIC AGONISTS | Clear Scientific, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-4582821-A | CONTACTING TUMOR CELLS WITH A PEPTIDE OR AMINO ACID HALO=METHYL KETONE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
| EP-0038357-A4 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS. | UNIV ILLINOIS (US) | 1982-03-22 | — | — | EP | disclosed |
| EP-0038357-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | University of Illinois Foundation (US) | 1981-10-28 | — | — | EP | disclosed |
| WO-1981001145-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | UNIV ILLINOIS (US) | 1981-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115275-A1 | RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF | RNGTT, RNASE1, UPF1 | MMP2 751/4885MMP9 2287/4885PLAU 156/4885 |
| US-20260124259-A1 | STAPHYLOCOCCUS PHAGE COMPOSITIONS AND COCKTAILS THEREOF | SPOUT1, NOP2, LSM8 | MMP2 1761/4885MMP9 1874/4885PLAU 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.